Evommune, Inc. (EVMN) Operating cash flow 2024–2025
Evommune, Inc. (EVMN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$76.4MFY2025 · since FY2024: -$58.2M → -$76.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$76.4M | -31.4% |
| FY2024 | -$58.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice